Amylyx Pharmaceuticals, Inc. (AMLX) vs Supernus Pharmaceuticals, Inc. (SUPN)

Amylyx Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Amylyx Pharmaceuticals, Inc. is the larger, with a market value of $3.8B against $2.5B — 1.5× the size. Supernus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 24.9% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −13.2%) and the higher return on invested capital (0.00% vs −12.4%). Across the 16 metrics below, Supernus Pharmaceuticals, Inc. leads on 11 and Amylyx Pharmaceuticals, Inc. on 5.